Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Emmanuel Petiot Becomes CEO of DEINOVE

January 9, 2013

PARIS, January 9, 2013 /PRNewswire/ –

Emmanuel PETIOT was formerly Director of Sales of NOVOZYMES in the United

States.

Jacques BITON, CEO of DEINOVE since 2007, is appointed Chairman of the

Scientific Advisory Board.

DEINOVE (Alternext Paris: Aldei) announces the appointment of Emmanuel Petiot,
formerly Director of Sales of NOVOZYMES North America, Inc. (the world leader in enzymes
and microorganisms), as CEO of DEINOVE. Jacques Biton, CEO since 2007, is appointed
Chairman of the Scientific Advisory Board of the company.

The primary goal of Emmanuel Petiot will be to position the company internationally
and to confirm its technological leadership by negotiating new agreements with corporate
partners in the various markets targeted by DEINOVE. The company has now developed a
powerful synthetic biology platform to optimize the natural enzymatic and metabolic
properties of the Deinococcus bacteria. This highly innovative approach has attracted
Emmanuel Petiot, a senior executive in the field of enzymes and microorganisms. His
extensive experience in biomass, biofuels and high value chemicals is a great asset for
DEINOVE.

Emmanuel Petiot was previously Director of Sales of Novozymes North America Inc., the
world leader in enzymes and microorganisms. For 9 years, he had a brilliant career in this
Danish industrial biotechnology company, holding executive positions in marketing, sales
and business development, both in Europe and the United States. He was also General
Manager of the French subsidiary of Novozymes. Previously, he held senior marketing and
sales positions at Dow Chemical and Air Liquide. Emmanuel Petiot graduated from EDHEC and
the Ecole Centrale, Paris.

“I am proud to become CEO of a company that many experts consider the rising star of
the green technology sector. Building upon the great R&D achievements of DEINOVE, I will
create value for the company and its shareholders by leading the DEINOL project to market,
developing projects in green chemistry and speeding up our international partnerships,”
says Emmanuel Petiot. “Jacques will continue to support DEINOVE by chairing our Scientific
Advisory Board.”

CEO since 2007, Jacques Biton has been the architect of the technological development
of the company, making Deinococcus bacteria a unique technology platform that has already
demonstrated its great potential for biomass degradation and bioethanol production.
Jacques Biton is now the Chairman of the International Scientific Advisory Board of
DEINOVE that includes Professor Miroslav RADMAN, one of the two founders of DEINOVE.

Chairman of the Board and founder of DEINOVE with Miroslav Radman, Dr. Philippe
POULETTY concludes: “Thanks to the work accomplished since 2006, the company is now
positioned as a leader in bacterial technologies. With our Board of Directors, we chose
Emmanuel Petiotto build the next steps of value creation. With our technology platform and
our leading intellectual property in the field of Deinococcus, Emmanuel and his team will
establish strong corporate partnerships, explore new markets, and grow the company
further.”

More information at http://www.deinove.com [C:\Documents and Settings\Marielle
Bricman\Mes documents\Deinove\nomination\www.deinove.com ]

SOURCE DEINOVE


Source: PR Newswire